Position in JNJ
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$16,202,016
+$784,208 QoQ
Shares Held
63,795
+1.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
2.65%
of 13F equity value
Holder Rank
#847
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ironwood Investment Counsel, LLC holds $31,349,950 across 7 Drug Manufacturers - General names. JNJ ranks #1 (51.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
63,795 | $16,202,016 | |
| 2 | AMGN |
Amgen Inc
|
20,809 | $7,535,355 | |
| 3 | LLY |
ELI LILLY & Co
|
3,573 | $4,285,563 | |
| 4 | ABBV |
AbbVie Inc.
|
9,119 | $2,294,705 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
3,171 | $400,624 | |
| 6 | PFE |
Pfizer Inc
|
15,465 | $372,397 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
4,500 | $259,290 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,202,016 | 63,795 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $15,417,808 | 63,074 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $13,260,321 | 64,075 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $11,991,482 | 64,672 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $9,717,344 | 63,616 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $10,300,985 | 62,114 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $8,847,417 | 61,177 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $10,057,605 | 62,061 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $9,013,394 | 61,668 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $9,731,216 | 61,516 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $9,917,253 | 63,272 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $209,453 | 64,105 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $10,432,063 | 63,026 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $9,259,390 | 59,738 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $9,884,804 | 55,957 | Shares | Sole | 2023-02-02 | |
| 2022-09-30 | $8,919,946 | 54,603 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $9,659,029 | 54,414 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $9,591,510 | 54,119 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $9,251,807 | 54,082 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $8,568,544 | 53,056 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $8,412,612 | 51,066 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $8,288,334 | 50,431 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $11,072,155 | 70,353 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $10,134,559 | 68,072 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $9,247,688 | 65,759 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $8,071,969 | 61,557 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||